439 related articles for article (PubMed ID: 31318098)
1. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.
Xu Y; Yuan XD; Wu JJ; Chen RY; Xia L; Zhang M; Han CH; Mou S
J Cell Biochem; 2020 Jan; 121(1):524-533. PubMed ID: 31318098
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
3. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
4. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T
Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine-modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis.
Li H; Tang Y; Ruan X; Zhang J; Liu H; Yu S; Chen H; Yang H; Zhang K; Chen K
Clin Transl Med; 2024 Apr; 14(4):e1658. PubMed ID: 38659080
[TBL] [Abstract][Full Text] [Related]
6. c-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt/β-catenin pathway.
Liu D; Liu Y; Zheng X; Liu N
Cell Death Dis; 2021 Feb; 12(2):191. PubMed ID: 33602903
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA YAP1 acts as the sponge of microRNA-21-5p to secure HK-2 cells from ischaemia/reperfusion-induced injury.
Huang T; Cao Y; Wang H; Wang Q; Ji J; Sun X; Dong Z
J Cell Mol Med; 2020 Apr; 24(8):4707-4715. PubMed ID: 32160412
[TBL] [Abstract][Full Text] [Related]
11. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
[No Abstract] [Full Text] [Related]
12. METTL14 aggravates podocyte injury and glomerulopathy progression through N
Lu Z; Liu H; Song N; Liang Y; Zhu J; Chen J; Ning Y; Hu J; Fang Y; Teng J; Zou J; Dai Y; Ding X
Cell Death Dis; 2021 Sep; 12(10):881. PubMed ID: 34580283
[TBL] [Abstract][Full Text] [Related]
13. EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.
Chen J; You H; Li Y; Xu Y; He Q; Harris RC
J Am Soc Nephrol; 2018 Sep; 29(9):2372-2385. PubMed ID: 30072422
[TBL] [Abstract][Full Text] [Related]
14. The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis.
Wu H; Wang L; Kang P; Zhou X; Li W; Xia Z
Int Immunopharmacol; 2024 May; 132():112002. PubMed ID: 38608473
[TBL] [Abstract][Full Text] [Related]
15. Loss of SAV1 in Kidney Proximal Tubule Induces Maladaptive Repair after Ischemia and Reperfusion Injury.
Moon D; Padanilam BJ; Park KM; Kim J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731829
[TBL] [Abstract][Full Text] [Related]
16. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
17. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
[TBL] [Abstract][Full Text] [Related]
18. METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.
Meng F; Liu Y; Chen Q; Ma Q; Gu S; Cui R; Cao R; Zhao M
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F839-F847. PubMed ID: 32954854
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
20. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]